CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-15 | Kelderman Kim Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +90,441 | 90,441 | ||
| 2025-08-15 | Bohnen Shane SVP - General Counsel | Option exercise | +1,718 | 4,912 | ||
| 2025-08-15 | Bohnen Shane SVP - General Counsel | Shares withheld for taxes | −527 | $53.60 | $28K | 4,385 |
| 2025-08-15 | Bohnen Shane SVP - General Counsel | Option exercise · Restricted Stock Units | −50 | 49 | ||
| 2025-08-15 | Bohnen Shane SVP - General Counsel | Option exercise · Restricted Stock Units | −1,668 | 3,338 | ||
| 2025-08-15 | Bohnen Shane SVP - General Counsel | Grant or award · Performance Restricted Stock Units | +13,992 | 13,992 | ||
| 2025-08-15 | Bohnen Shane SVP - General Counsel | Grant or award · Restricted Stock Units | +6,996 | 6,996 | ||
| 2025-08-15 | Bohnen Shane SVP - General Counsel | Grant or award · Stock Option (Right to Buy) | +17,897 | 17,897 | ||
| 2025-08-15 | McManus Matthew President - Diag & Spatial Bio | Option exercise | +2,637 | 5,615 | ||
| 2025-08-15 | McManus Matthew President - Diag & Spatial Bio | Shares withheld for taxes | −880 | $53.60 | $47K | 4,735 |
| 2025-08-15 | McManus Matthew President - Diag & Spatial Bio | Option exercise · Restricted Stock Units | −2,637 | 5,275 | ||
| 2025-08-15 | McManus Matthew President - Diag & Spatial Bio | Grant or award · Performance Restricted Stock Units | +19,243 | 19,243 | ||
| 2025-08-15 | McManus Matthew President - Diag & Spatial Bio | Grant or award · Restricted Stock Units | +9,622 | 9,622 | ||
| 2025-08-15 | McManus Matthew President - Diag & Spatial Bio | Grant or award · Stock Option (Right to Buy) | +24,614 | 24,614 | ||
| 2025-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Option exercise | +2,623 | 15,915 | ||
| 2025-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Shares withheld for taxes | −803 | $53.60 | $43K | 15,112 |
| 2025-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Option exercise · Restricted Stock Units | −2,623 | 5,246 | ||
| 2025-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Performance Restricted Stock Units | +19,355 | 19,355 | ||
| 2025-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Restricted Stock Units | +9,678 | 9,678 | ||
| 2025-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Stock Options (Right to Buy) | +24,758 | 24,758 |
Page 11 of 32 · 626 trades